NeurologyLive® Staff

home / authors / neurologylive-staff

Articles

Richard S. Isaacson, MD

It's Complicated: Why Aducanumab's Approval Raises More Questions Than Answers

NeurologyLive® Staff
June 11th 2021

Alzheimer disease experts Richard S. Isaacson, MD, and Marc E. Agronin, MD, discuss the recent aducanumab approval and some of the clinical community's concerns.

This Week on NeurologyLive — June 7, 2021

This Week on NeurologyLive — June 7, 2021

NeurologyLive® Staff
June 7th 2021

Here's what is coming soon to NeurologyLive.

Experts Call for Better Trial Design, Alzheimer Disease Vaccine Shows Safety, FDA Accepts IND for LION-101

Experts Call for Better Trial Design, Alzheimer Disease Vaccine Shows Safety, FDA Accepts IND for LION-101

NeurologyLive® Staff
June 5th 2021

Neurology News Network for the week ending June 5, 2021.

NeurologyLive Friday 5 — June 4, 2021

NeurologyLive Friday 5 — June 4, 2021

NeurologyLive® Staff
June 4th 2021

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending June 4, 2021.

This Week on NeurologyLive — May 31, 2021

This Week on NeurologyLive — May 31, 2021

NeurologyLive® Staff
May 31st 2021

Here's what is coming soon to NeurologyLive.

ANVS401 Shows Promise in Alzheimer Disease, FDA Approves IND for Ketamine in Parkinson, MedRhythms Collaborates With Massachusetts General Hospital

ANVS401 Shows Promise in Alzheimer Disease, FDA Approves IND for Ketamine in Parkinson, MedRhythms Collaborates With Massachusetts General Hospital

NeurologyLive® Staff
May 29th 2021

Neurology News Network for the week ending May 29, 2021.

NeurologyLive Friday 5 — May 28, 2021

NeurologyLive Friday 5 — May 28, 2021

NeurologyLive® Staff
May 28th 2021

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending May 28, 2021.

ALS Research and Care: What Can We Look Forward To?

ALS Research and Care: What Can We Look Forward To?

Matthew B. Harms, MD;NeurologyLive® Staff
May 26th 2021

Matthew B. Harms, MD, associate professor of neurology at Columbia and medical consultant for the Muscular Dystrophy Association, shares his thoughts on the current state of ALS care.

This Week on NeurologyLive — May 24, 2021

This Week on NeurologyLive — May 24, 2021

NeurologyLive® Staff
May 24th 2021

Here's what is coming soon to NeurologyLive.

ET Associated With Substantial HCRU, MS Phenotypes Share Common Mechanisms, Hypertension Risk in Menopausal Women With Migraine

ET Associated With Substantial HCRU, MS Phenotypes Share Common Mechanisms, Hypertension Risk in Menopausal Women With Migraine

NeurologyLive® Staff
May 22nd 2021

Neurology News Network for the week ending May 22, 2021.

NeurologyLive Friday 5 — May 21, 2021

NeurologyLive Friday 5 — May 21, 2021

NeurologyLive® Staff
May 21st 2021

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending May 21, 2021.

This Week on NeurologyLive — May 17, 2021

This Week on NeurologyLive — May 17, 2021

NeurologyLive® Staff
May 17th 2021

Here's what is coming soon to NeurologyLive.

Gene Therapy in SLC13A5 Deficiency, DMTs Reduce Risk of Disability in Pediatric MS, FASTEST Phase 3 Study Announced

Gene Therapy in SLC13A5 Deficiency, DMTs Reduce Risk of Disability in Pediatric MS, FASTEST Phase 3 Study Announced

NeurologyLive® Staff
May 15th 2021

Neurology News Network for the week ending May 15, 2021.

NeurologyLive Friday 5 — May 14, 2021

NeurologyLive Friday 5 — May 14, 2021

NeurologyLive® Staff
May 14th 2021

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending May 14, 2021.

African Americans at Higher Risk of Stroke

African Americans at Higher Risk of Stroke

NeurologyLive® Staff
May 14th 2021

African Americans are not only at increased risk of having a stroke, but they're also at increased risk of being debilitated by or dying from a stroke.

Consumer Health: Stroke Awareness

Consumer Health: Stroke Awareness

NeurologyLive® Staff
May 12th 2021

Understanding the signs and symptoms stroke during National Stroke Awareness Month.

This Week on NeurologyLive — May 10, 2021

This Week on NeurologyLive — May 10, 2021

NeurologyLive® Staff
May 10th 2021

Here's what is coming soon to NeurologyLive.

VY-HTT01 IND Accepted, SUDEP Associated With Abnormal Cardiac Response, Humoral Response in MS DMTs Identified

VY-HTT01 IND Accepted, SUDEP Associated With Abnormal Cardiac Response, Humoral Response in MS DMTs Identified

NeurologyLive® Staff
May 8th 2021

Neurology News Network for the week ending May 8, 2021.

NeurologyLive Friday 5 — May 7, 2021

NeurologyLive Friday 5 — May 7, 2021

NeurologyLive® Staff
May 7th 2021

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending May 7, 2021.

Unique Neurologic Symptoms Lead to Surprising Cancer Diagnosis

Unique Neurologic Symptoms Lead to Surprising Cancer Diagnosis

NeurologyLive® Staff
May 5th 2021

Lightheadness, loss of balance, vision changes, and abnormal eye movements led to the discovery of cancer in one specific patient.

This Week on NeurologyLive — May 3, 2021

This Week on NeurologyLive — May 3, 2021

NeurologyLive® Staff
May 3rd 2021

Here's what is coming soon to NeurologyLive.

Tofersen to Begin Expanded Access, FDA Grants De Novo to Chronic Stroke Rehab Therapy, Brain MRI to Predict Post-Partum Relapses

Tofersen to Begin Expanded Access, FDA Grants De Novo to Chronic Stroke Rehab Therapy, Brain MRI to Predict Post-Partum Relapses

NeurologyLive® Staff
May 1st 2021

Neurology News Network for the week ending May 1, 2021.

NeurologyLive Friday 5 — April 30, 2021

NeurologyLive Friday 5 — April 30, 2021

NeurologyLive® Staff
April 30th 2021

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending April 30, 2021.

This Week on NeurologyLive — April 26, 2021

This Week on NeurologyLive — April 26, 2021

NeurologyLive® Staff
April 26th 2021

Here's what is coming soon to NeurologyLive.

Stroke Common Cause of Seizures, Inebilizumab Demonstrates Continued Benefits, Fremanezumab Safe in Patients With CV Risk

Stroke Common Cause of Seizures, Inebilizumab Demonstrates Continued Benefits, Fremanezumab Safe in Patients With CV Risk

NeurologyLive® Staff
April 24th 2021

Neurology News Network for the week ending April 24, 2021.

NeurologyLive Friday 5 — April 23, 2021

NeurologyLive Friday 5 — April 23, 2021

NeurologyLive® Staff
April 23rd 2021

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending April 23, 2021.

This Week on NeurologyLive — April 19, 2021

This Week on NeurologyLive — April 19, 2021

NeurologyLive® Staff
April 19th 2021

Here's what is coming soon to NeurologyLive.

Risdiplam Demonstrates Continued Improvements in SMA, Cortical Hyperexcitability in ALS, Retinal Atrophy Modulated With Rituximab

Risdiplam Demonstrates Continued Improvements in SMA, Cortical Hyperexcitability in ALS, Retinal Atrophy Modulated With Rituximab

NeurologyLive® Staff
April 17th 2021

Neurology News Network for the week ending April 17, 2021.

NeurologyLive Friday 5 — April 16, 2021

NeurologyLive Friday 5 — April 16, 2021

NeurologyLive® Staff
April 16th 2021

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending April 16, 2021.

This Week on NeurologyLive — April 12, 2021

This Week on NeurologyLive — April 12, 2021

NeurologyLive® Staff
April 12th 2021

Here's what is coming soon to NeurologyLive.

<1
...
212223242526272829
...
36>

Latest Updated Articles

FDA Approves Diazoxide Choline Extended-Release Tablets for Hyperphagia in Prader-Willi Syndrome
Published: March 27th 2025 | Updated: March 28th 2025
FDA Approves Diazoxide Choline Extended-Release Tablets for Hyperphagia in Prader-Willi Syndrome
BTK Inhibitor Tolebrutinib Shows Greater Effectiveness in Multiple Sclerosis with Higher Paramagnetic Rim Lesion Counts
Published: March 4th 2025 | Updated: March 19th 2025
BTK Inhibitor Tolebrutinib Shows Greater Effectiveness in Multiple Sclerosis with Higher Paramagnetic Rim Lesion Counts
FDA Approves Vertex Pharmaceuticals' Suzetrigine for Acute Pain Management
Published: January 30th 2025 | Updated: February 21st 2025
FDA Approves Vertex Pharmaceuticals' Suzetrigine for Acute Pain Management
Cerebrospinal Fluid Lipids Shows Promise as Biomarkers for Differentiating NMOSD and MS
Published: February 15th 2025 | Updated: February 18th 2025
Cerebrospinal Fluid Lipids Shows Promise as Biomarkers for Differentiating NMOSD and MS
FDA Approves Apomorphine Infusion Device SPN-830 as New Parkinson Treatment
Published: February 4th 2025 | Updated: February 6th 2025
FDA Approves Apomorphine Infusion Device SPN-830 as New Parkinson Treatment
FDA Approves Axsome Therapeutics’ AXS-07 for Migraine Treatment
Published: January 30th 2025 | Updated: February 4th 2025
FDA Approves Axsome Therapeutics’ AXS-07 for Migraine Treatment
© 2025 MJH Life Sciences

All rights reserved.